The FDA-approved OmniaSecure defibrillation lead from Medtronic is a thin wire that connects an implantable cardioverter defibrillator to the heart.

The ILH–IITH Bioengineering Centre of Excellence was inaugurated on Wednesday at the Hyderabad campus in collaboration with ...

In a major breakthrough in cardiac care, doctors in Thiruvananthapuram have successfully performed the first Impella-assisted angioplasty in South Kerala, saving the life of a 38-year-old patient ...

Cryotherapy Market OverviewThe Cryotherapy Market is projected to grow at a rate of around 7% by 2028, driven by rising incidences of sports injuries and cancer, continuous technological advancements, ...

A final option, less commonly used, is a technique called atherectomy. This treatment uses a device that cuts or grinds away the hardened deposition (atheroma) within the artery. Atherectomy is less ...

A new development in wireless sensing technology that can reliably screen for five common pulmonary diseases could lead to ...

For high-risk patients, the method could offer a safer alternative to open-heart surgery.

In the AXSANA/EUBREAST 3(R) study, researchers compared data about recurrence outcomes of more-invasive and less-invasive lymph node procedures.

Sensydia, a medical technology company advancing non-invasive cardiac assessment, today announced that the American Medical Association (AMA) has published a new industry-first Category III CPT® code, ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

Auricular vagal neuromodulation therapy is a non-invasive and non-surgical treatment that could aid cardiovascular disease ...